Chronic Schizophrenia is a long term case of Schizophrenia which is a mental disorder that affects a person’s ability to tell what is real and not real, to act normal, and to think clearly. Schizophrenia is usually considered a chronic disorder and episodes repeat themselves during someone’s life. Chronic Schizophrenia lasts for prolonged periods of time with symptoms that include social withdrawal, lack of motivation, and limited activity. When symptoms of Chronic Schizophrenia persist, individuals can neglect themselves and continue useless activities at great length. Chronic Schizophrenia differs from Schizophrenia because the episodes are milder and longer lasting in the chronic form.
Chronic Schizophrenia Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Chronic Schizophrenia below!
For more information on how to use Laverne, please read the How to Guide.
We have 2732 products for the study of Chronic Schizophrenia that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Chronic Schizophrenia is also known as Chronic Schizophrenic, Schizophrenia Chronic.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.